Lab Med Qual Assur 2021; 43(1): 19-24
Published online March 31, 2021
https://doi.org/10.15263/jlmqa.2021.43.1.19
Copyright © Korean Association of External Quality Assessment Service.
John Jeongseok Yang1 , Jin Seok Kim1
, Yousun Chung2
, Hyungsuk Kim3
, Dae-Hyun Ko1
, Sang-Hyun Hwang1
, and Heung-Bum Oh1
1Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine; 2Department of Laboratory Medicine, Kangdong Sacred Heart Hospital; 3Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea
Correspondence to:Dae-Hyun Ko
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea
Tel +82-2-3010-4504
Fax +82-2-478-0884
E-mail daehyuni1118@amc.seoul.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background: This study summarizes a survey conducted to improve and expand the external quality assessment (EQA) scheme for transfusion in Korea.
Methods: The EQA items provided by the College of American Pathologists, Royal College of Pathologists of Australasia, National External Quality Assessment Service, and German program were explored. A commercially operated EQA program was also included in the survey.
Results: Items not included in the Korean EQA programs included extended antigen typing, electronic cross-matching, eluate survey, and fetal red cell detection. Granulocyte- and platelet-related testing was also not covered by the Korean program. There were issues regarding establishing the criteria for acceptable ranges and manufacturing of EQA materials.
Conclusions: We successfully conducted a survey for the improvement and expansion of EQA for transfusion medicine. A pilot project for extended antigen typing is expected to be implemented in 2021, and ongoing expansion will continue in the following years.
Keywords: Transfusion medicine, Proficiency testing, External quality assessment
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |